U.S. markets closed
  • S&P 500

    4,596.42
    +44.74 (+0.98%)
     
  • Dow 30

    35,730.48
    +239.79 (+0.68%)
     
  • Nasdaq

    15,448.12
    +212.28 (+1.39%)
     
  • Russell 2000

    2,297.98
    +45.49 (+2.02%)
     
  • Crude Oil

    83.06
    +0.40 (+0.48%)
     
  • Gold

    1,800.60
    +1.80 (+0.10%)
     
  • Silver

    24.12
    -0.07 (-0.27%)
     
  • EUR/USD

    1.1688
    +0.0081 (+0.70%)
     
  • 10-Yr Bond

    1.5680
    +0.0390 (+2.55%)
     
  • GBP/USD

    1.3795
    +0.0053 (+0.38%)
     
  • USD/JPY

    113.5600
    -0.2500 (-0.22%)
     
  • BTC-USD

    60,801.88
    +1,790.40 (+3.03%)
     
  • CMC Crypto 200

    1,491.73
    +72.36 (+5.10%)
     
  • FTSE 100

    7,249.47
    -3.80 (-0.05%)
     
  • Nikkei 225

    28,820.09
    -278.15 (-0.96%)
     

Biogen Rockets Into A Breakout After Beating Mylan In A Patent Battle

·2 min read
Biogen Rockets Into A Breakout After Beating Mylan In A Patent Battle
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Biogen stock rocketed Wednesday after U.S. patent officials agreed to uphold a key patent covering Tecfidera for several more years. Tecfidera is an important multiple sclerosis drug.